E

Epizyme

114 employees

Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Biopharma
Health Care

Date founded

2007

Funding rounds raised

Total raised

$100M

from 4 investors over 4 rounds

E

Epizyme raised undisclosed on January 1, 2020

Investors: Frazier Healthcare Partners

E

Epizyme raised $100M on November 7, 2019

Investors: Royalty Pharma

E

Epizyme raised $10M on February 12, 2014

Investors: Celgene

E

Epizyme raised $7.5M on June 23, 2011

Investors: The Leukemia & Lymphoma Society

FAQ